SIMULTANEOUS DEVELOPMENT OF PRO QUESTIONNAIRES FOR USE IN CLINICAL TRIALS AND 'REAL-WORLD' SITUATIONS

Author(s)

Shields A1, Stokes J2, Foley C2, Banderas B2, Sundaram M3
1Adelphi Values, Boston, MA, USA, 2Adelphi Values USA, Boston, MA, USA, 3AbbVie Inc., North Chicago, IL, USA

OBJECTIVES: Patient reported outcomes (PROs) are variously used across drug development and post-marketing.  In this way, outcomes researchers are often tasked with developing PRO questionnaires to suit these multiple contexts. The purpose of this research is to provide suggestions and an example of how outcomes researchers might approach simultaneous development of a PRO questionnaire for use in two unique contexts - clinical trials to evaluate efficacy claims and in clinical settings to facilitate patient-provider discussions. METHODS: In the context of developing and modifying sign- and symptom-focused tools for patients with chronic plaque psoriasis, questionnaire development was informed by a) literature review, expert advice meetings (n=3), patient concept elicitation interviews (N=60), b) concept selection and questionnaire construction activities, c) content evaluation (N=20), and d) and psychometric evaluation (N=200).  Given the multiple contexts of use intended for the questionnaire, instrument developers created distinct, albeit corresponding questionnaires paying close attention to content, response options, recall period, focus of measurement (e.g., symptom at its worst vs. symptom on average), and number of items.  RESULTS: Developers simultaneously created and modified two questionnaires. The Self-Assessment of Psoriasis Symptoms for Clinical Trials (SAPS-CT) has nine items and asks respondents to rate their symptom “at its worst” in the 24 hours prior to assessment while the SAPS for Real World (SAPS-RW) has six items and asks respondents to rate their symptoms “on average” in the seven days prior to assessment.  Results support both tools as content valid and capable of generating reliable and valid scores when administered among patients with chronic plaque psoriasis. CONCLUSIONS: Though not without challenges and limitations, the methods and results presented here may provide a model for outcomes researchers to more efficiently develop unique versions of a questionnaire suitable to the multiple contexts for which they are often asked to create PRO questionnaires.  

Conference/Value in Health Info

2016-05, ISPOR 2016, Washington DC, USA

Value in Health, Vol. 19, No. 3 (May 2016)

Code

PRM144

Topic

Methodological & Statistical Research

Topic Subcategory

PRO & Related Methods

Disease

Sensory System Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×